Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
Completed
Conditions studied: Immunologic Deficiency Syndromes, Neoplasms
In brief
The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be utilized.
Key facts
- Study ID
- NCT00001158
- Run by
- National Cancer Institute (NCI)
- Starts
- 1977-04-01
- Expected to finish
- 2000-03-01
- Last updated by the study team
- 2008-03-05
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
Where it is running
- National Cancer Institute (NCI) — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.